PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical studies
Collaborators
About Us
News
In the news
Thought Leadership
Press releases
Meetings & Events
Awards
Contact Us
Careers
US openings
Israel openings
Order a test
PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical Studies
Collaborators
News
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
Company
About us
Careers
Contact us
Order a test
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
September 20, 2021
OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response
Original source
here.
Recent news
January 17, 2025
OncoHost wins 2025 BIG Innovation Award for healthcare
Read more
January 16, 2025
OncoHost Wins 2025 BIG Innovation Award for Healthcare
Read more
January 15, 2025
Proteomics Predictor for Immunotherapy Benefit
Read more
January 15, 2025
OncoHost Celebrates BIG Innovation Award in Precision Oncology
Read more
December 30, 2024
What’s Ahead for the Health Care Industry in 2025?
Read more
December 12, 2024
“Back to the Future”: Developments in Immunotherapy with David Gandara, MD
Read more
Read all news
